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Background: Morbidity and mortality from respiratory infections are higher in resource-limited countries than
developed countries, but limited studies have been conducted in resource-limited settings to examine pathogens
from patients with acute respiratory infections. Influenza surveillance has been conducted in Zambia since 2008;
however, only 4.3% of patients enrolled in 2011–2012 were positive for influenza. Therefore, we examined non-influenza
respiratory pathogens in children with severe acute respiratory illness (SARI) in Zambia, to estimate the scope of disease
burden and determine commonly-identified respiratory pathogens.
Methods: Two reverse transcriptase polymerase chain reaction (rRT-PCR) methods (single and multiplex) were used to
analyze nasopharyngeal and throat swabs collected from SARI cases under five years of age from January 2011 through
December 2012. All specimens were negative for influenza by rRT-PCR. The panel of singleplex reactions targeted seven
viruses, while the multiplex assay targeted thirty-three bacteria, fungi, and viruses.
Results: A set of 297 specimens were tested by singleplex rRT-PCR, and a different set of 199 were tested by multiplex
rRT-PCR. Using the singleplex assay, 184/297 (61.9%) specimens were positive for one or more viruses. The most prevalent
viruses were human rhinovirus (57/297; 19.2%), human adenovirus (50/297; 16.8%), and respiratory syncytial virus (RSV)
(45/297; 15.2%).
Using multiplex PCR, at least one virus was detected from 167/199 (83.9%) specimens, and at least one bacteria was
detected from 197/199 (99.0%) specimens. Cytomegalovirus (415/199; 208.5%) and RSV (67/199; 33.7%) were the most
commonly detected viruses, while Streptococcus pneumonie (109/199; 54.8%) and Moraxella catarrhalis (92/199; 46.2%)
were the most commonly detected bacteria.
Conclusions: Single infections and co-infections of many viruses and bacteria were identified in children with SARI. These
results provide an estimate of the prevalence of infection and show which respiratory pathogens are commonly identified
in patients. Further studies should investigate causal associations between individual pathogens and SARI.
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The World Health Organization (WHO) estimates that
20% of hospitalizations in children under 5 years old are
attributable to severe acute respiratory illness (SARI), and
90% of these illnesses are a result of pneumonia [1]. Fur-
thermore, the WHO estimates that acute respiratory infec-
tions account for 1.9 to 2.2 million childhood deaths
annually, with 42% occurring in Africa [2,3]. Bacterial in-
fections, especially those that cause pneumonia, are im-
portant because they substantially contribute to childhood
mortality [4-7]. Viruses also play a role, because primary
infection with viral pathogens can pre-dispose children to
secondary bacterial infection [8-10], and a viral diagnosis
can minimize the overuse of antibiotics [11]. Furthermore,
co-infection with multiple respiratory pathogens is com-
mon [12-15].
In 2012, an influenza surveillance study in Zambia
reported that seasonal influenza and its attributed illnesses
were associated with both mild and severe respiratory ill-
ness that contributed to outpatient and inpatient respira-
tory illness, with children less than 5 years of age being
the most affected [16]. However, only 128 (4.3%) of 2,976
patients with respiratory illness in 2011–2012 were posi-
tive for influenza. As such, it is necessary to broaden de-
tection to include other respiratory pathogens, to estimate
the scope of disease burden and determine which respira-
tory pathogens are commonly identified in SARI patients.
There has been little research into non-influenza pathogens
identified in SARI patients in Zambia. As a result, little is
known about the pathogens involved in severe respiratory
infections affecting children under five in Zambia.
To address this challenge, we identified pathogens
from hospitalized children under five with SARI in
Lusaka, Zambia. The aim of this study was to detect
upper respiratory pathogens in specimens that were
previously laboratory-confirmed influenza negative, to
investigate the relative frequency of isolation, seasonal-
ity, and clinical diagnosis of various pathogens identi-
fied from SARI patients.Methods
Site and population
From January 2011 to December 2012, we conducted
influenza surveillance at a sentinel site at the Pediatrics
Department, University Teaching Hospital (UTH) in
Lusaka, Zambia. The UTH is Zambia’s largest reference
hospital, with a population of over 5,000 children seen
in one calendar year; of these, over 2,000 are acute re-
spiratory infection admissions. Zambia has two distinct
seasons: the cold season (May to August) and the hot
season (September to April). Surveillance was con-
ducted year-around, and patients were drawn from
throughout Lusaka.Case definitions
We enrolled patients presenting to the UTH with SARI,
defined according to a WHO case definition [17] of:
Patient ≤ 5 years of age admitted with less than 7 days
duration of illness, with temperature ≥38°C OR history of
fever and cough OR sore throat and difficulty breathing.
Hospitalization was a required part of all SARI cases.
For each patient, surveillance officers recorded specific
signs and symptoms so that case classification could be
validated with the case definition form [17].
Specimen collection
Eligible patients were identified by surveillance officers at
the UTH Pediatrics Department, and a WHO question-
naire [17] was used to capture demographic data, clinical
information, and influenza vaccination status from parents
or guardians representing the children. Written informed
consent was obtained from guardians. Combined oropha-
ryngeal (OP) and nasopharyngeal (NP) swabs were col-
lected. A cotton flocked swab was used to rub the back of
the OP mucosal membrane for 1–2 seconds, and then
placed into 1.5 ml of commercially available Copan
Universal Transport medium (UTM) (Copan, Brescia,
Italy). A tipped flexible aluminum-shafted NP swab was
then inserted into the nose until it reached the naso-
pharynx, where it was rotated for 1–2 seconds. The NP
swab was inserted into the same 1.5 ml vial with UTM
as the OP swab. Respiratory specimens were stored at
2–8°C before being transported daily at 4°C from the
Pediatric Department to the Virology Laboratory,
Department of Microbiology and Pathology, UTH.
Specimen processing
Specimens with a laboratory confirmed influenza negative
result by real-time reverse transcriptase PCR (rRT-PCR)
were processed in the current study. The rationale for this
was to detect other pathogens other than influenza in chil-
dren with SARI. The influenza rRT-PCR test was the stand-
ard assay from the Centers for Disease Control and
Prevention which identifies and subtypes seasonal influenza
A/H1N1, seasonal influenza A/H3N2, 2009 pandemic A/
H1N1, and influenza B. Specimens were processed only if
the internal control human ribonuclease gene had a cycle
threshold ≤35, indicating a high-quality specimen [13]. Of
the specimens collected during the study period, 4.3%
tested positive for influenza; these were excluded from the
study. The singleplex assay targeted seven viruses, while the
multiplex targeted thirty-three bacteria, fungi, and viruses.
Both methods were internally controlled and semi-
quantitative. The methods were not directly compared;
different sets of samples were used for each method. There-
fore, analysis for each method is presented separately.
The singleplex rRT-PCR tests were performed using the
7500 fast real-time PCR system (Applied BioSystems,
Table 2 Distribution of viruses among SARI patients using sin
Singleplex PCR (n = 297)
Single infection Co-infection Total
Viral pathogen n (%)* n (%)
HRV 34 (11.4) 23 (7.7) 57
HPIV 1 6 (2.0) 2 (0.7) 8
HPIV 2 4 (1.3) 4 (1.3) 8
HPIV 3 3 (1.3) 1 (0.3) 4
RSV 24 (8.1) 23 (7.7) 45
HADV 27 (9.1) 26 (8.7) 50
HMPV 11 (3.7) 3 (1.3) 14
Total 109 (36.7) 82 (27.6) 184
*The total number of specimens tested by each assay was used as the denominato
because of instances were one virus had multiple infections with other pathogens.
Table 1 Demographic and clinical characteristics of SARI











Difficult breathing 399 (80.4)
Chest in-drawing 188 (37.9)





Lower RTI 16 (3.2)
Bronchitis 7 (1.4)
TB 7 (1.4)
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influenza virus-1, 2, 3 (HPIV), human rhinovirus (HRV),
human adenovirus (HADV), human metapneumovirus
(HMPV), and respiratory syncytial virus (RSV). Extraction
of viral nucleic acid was conducted using a Qiagen body
fluid 250 mini extraction kit (Life Technologies, Germany).
The PCR protocol, including primers and probes for real-
time PCR detection, were from the Centers for Disease
Control and Prevention (CDC) in Atlanta, Georgia [13].
The multiplex rRT-PCR was performed with the Fast
Track Diagnostic (FTD) kit (Junglinster, Luxembourg).
The FTD kit consisted of eight multiplex RT-PCR reac-
tions, targeted 33 respiratory pathogens, and was per-
formed using the 7500 fast real-time PCR system
according to the protocol instructions (Fast Track Diag-
nostics, Luxembourg) [18]. The following viral and bacter-
ial pathogens were FTD targets: Influenza A, B, and C,
HPIV 1, 2, 3, and 4, coronaviruses NL63 (cor63), cor 229,
cor 43 and HKU 1, HMPV A and B, HRV, RSV A and B,
HADV, Enteroviruses (EV), Parechovirus (PV), Bocavirus
(HBoV), Cytomegalovirus (CMV), Pneumocystis jirovecii
(PCP), Mycoplasma pneumoniae (Mpneu), Chlamydia
pneumoniae (Cpneu), Streptococcus pneumoniae (Spneu),
Haemophilus influenzae type B (HIB), Staphylococcus aur-
eus (Saurs), Moraxella catarrhalis (Morax), Bordetella per-
tussis (Bord), Klebsiella pneumoniae (Kpneu), Legionella
species (Legio), Salmonella species (Salm), and Haemophi-
lus influenzae species. Even though this assay has the
capability to detect 33 pathogens, not all pathogens weregle and multiplex PCR
Multiplex PCR (n = 199)
Single infection Co-Infection
Viral pathogen n (%) n (%) Total
HRV 3 (1.5) 45 (22.1) 48
HPIV 1 0 (0) 15 (7.5) 15
HPIV 3 21 (0.1) 10 (5.0) 31
Cor43 1 (0.5) 22 (11.0) 23
HPIV 4 0 (0.0) 0 (0.0) 0
RSVA + B 8 (4.0) 59 (29.6) 67
CMV 58 (29.1) 357 (179.4) 415
HADV 4 (2.0) 69 (34.7) 73
HMPV 0 (0.0) 41 (20.6) 41
EV/PV 1 (0.5) 12 (6.0) 13
COR 229 0 (0.0) 0 (0.0) 0
COR 63 1 (0.5) 22 (11.1) 23
COR HKU 0 (0.0) 1 (0.0) 1
HBoV 0 (0.0) 77 (38.7) 77
Total 78 (39.2) 730 (366.8) 808
r for each percentage and the total of co-infections is high than total tested
Figure 1 (See legend on next page.)
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Figure 1 Seasonality of viruses identified from specimens collected in Lusaka, Zambia from January 2011 to December 2012.
Specimens collected throughout the year were analyzed for seasonality. The total number of specimens collected each month was plotted, along
with the number of times each virus was identified per month. The following viruses were monitored: Human parainfluenza viruses 1,2,3 and
4 (HPIV 1, 2, 3 and 4), coronaviruses NL63 (cor63), cor 229, cor 43 and HKU 1, Human metapneumoviruses A and B (HMPV A and B), rhinoviruses, (HRV)
Respiratory syncytial viruses A and B (RSV A/B), Adenoviruses (HADV), Enteroviruses (EV), Parechovirus (PV), Bocavirus (HBoV), and Cytomegalovirus (CMV).
Simusika et al. BMC Infectious Diseases  (2015) 15:52 Page 5 of 10detected from our samples. In particular, in agreement
with the influenza-specific rRT-PCR test, all specimens
were negative for influenza with the FTD kit. Nucleic acid
extraction for multiplex rRT-PCR was conducted with the
EasyMAG Respiratory specimen nucleic acid extraction
protocol according to the manufacturer’s instructions
(EasyMAG 2.0, bioMérieux, Marcy I Etoile, France).Data analysis
Data were entered into a Microsoft Access database
(Microsoft Corporation, Washington, USA). SPSS version
16 (IBM, New York, USA) and Microsoft Excel (Microsoft
Corporation, Washington, USA) were used for analysis of
the seasonal distribution and clinical characteristics of the
various pathogens. SARI cases with symptom onset of
more than 7 days were excluded, to minimize the possibil-
ity of false-negative results. The duration of illness of was
calculated based on the date of onset of illness to the date
of clinical investigation at the sentinel site.Ethical approval
Ethical approval was obtained from the University of Zambia
Biomedical Research Ethics Committee. Institutional review
was waived by CDC because this study was considered to be
a non-research public health activity. Written informed con-
sent was obtained from the guardians of all participants for
influenza testing, and the University of Zambia Biomedical
Research Ethics Committee waived the requirement to re-
consent for additional testing.Results
Study population
During the study period, 496 patients who met the SARI
case definition and inclusion criteria were enrolled and
tested. HIV status of patients was unavailable. The median
age of the participants was 9.6 months old. At admission
cough was present in 483 (97.4%) of the patients, followed
by fever (469; 94.6%) and difficult breathing (399; 80.4%)
(Table 1). The most common clinical diagnosis, as deter-
mined by attending physicians, was pneumonia (384;
77.4%), followed by bronchiolitis (56; 11.3%). No partici-
pant had been vaccinated for influenza prior to being en-
rolled in this study, and the median number of days
between symptom onset and enrolment was 3.75 days
(data not shown).Pathogen detection and characterization
One or more pathogens was detected in 381/496 (76.8%)
specimens At least one virus was detected from 358/496
(72.2%) of all of the specimens, and at least one bacteria
was detected from 197/199 (98.9%) of the specimens tested
with the multiplex assay. By singleplex PCR, HRV was the
most commonly detected virus (57/297; 19.2%), followed
by HADV (50/297; 16.8%), RSV (45/297; 15.2%), and
HMPV (14/297; 4.7%) (Table 2). By multiplex PCR, CMV
was the most commonly detected virus (415/199; 208.5),
followed by RSV (67/199; 33.7%). (Table 2), and the most
commonly detected bacteria were S. pneumoniae (109/199;
54.8%), M. catarrhalis (92/199; 46.2%), and H. influenzae
(81/199; 40.7%). Using the multiplex assay, single viral in-
fections accounted for 78/199 (39.2%) of cases (Table 2),
while multiple infections of viral/viral and bacteria/viral
nature were more than the total specimen collected
(Table 2).
Seasonal distribution
Zambia has a distinct influenza season, fromMay to August.
In contrast to influenza, most pathogens studied here were
detected throughout the year (Figures 1 and 2). RSV was de-
tected year round, with the highest RSV prevalence in April
and May. HMPV was most often identified between January
and March, which is the rainy season in Zambia. We did
not observe a distinct seasonal pattern with the rest of the
viruses or with any of the bacteria.
Discussion
To our knowledge, this study reports for the first time the
pathogens detected from many SARI cases in Zambia.
Bacterial and viral pathogens were detected from many
SARI cases among hospitalized children in Zambia, sug-
gesting that viruses and bacteria are major causes of
significant respiratory illnesses [1,2,19].
We detected at least one pathogen in 381/496 (76.8%)
samples from SARI cases. A relatively similar pattern was
observed in Madagascar, which identified viruses and/or
atypical bacteria in 74.6% of 295 samples [20,21]. Viral
pathogens were detected in 184/297 (62.0%) of the sam-
ples by singleplex and in 167/199 (83.9%) of the samples
by multiplex assay. The higher percentage in the multiplex
is likely due to CMV, which was the most commonly de-
tected virus with the multiplex but was not a target of the
singleplex assay. The high prevalence of CMV in our study
is intriguing, and while in the current study we cannot
Figure 2 (See legend on next page.)
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Figure 2 Seasonality of bacteria/fungi identified from specimens collected in Lusaka, Zambia from January 2011 to December 2012.
Specimens collected throughout the year were analyzed for seasonality. Total numbers of specimens collected each month were plotted, in
addition to the number of times each bacteria/fungus was identified per month. The following pathogens were monitored: Bordetella pertussis
(Bord), Haemophilus influenza species (Haeinf ), Haemophilus influenzae type B (HIB), Moraxella catarrhalis (Morax), Staphylococcus aureus (Saurs),
Klebsiella pneumoniae (Kpneu), Streptococcus pneumoniae (Spneu), Salmonella species (Salm), Chlamydia pneumonia (C pneu), Pneumocystis
jirovecii (PCP).
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CMV was identified, we plan to further examine the po-
tential role of CMV in SARI in the future.
Bacterial pathogens were detected in 197/199 (98.9%)
of the samples by the multiplex assay. This prevalence of
bacterial detection is comparable to studies done in rural
India and among children in Japan, which showed that
90.4% of children carried bacteria pathogens and at least
55.3% had more than one bacterial pathogen [22-24].
According to our study, 119/199(54.8%) of the cases had
S. pneumoniae, which is relatively comparable to other
studies that reported that S. pneumoniae was detected
from 75.2% of cases [25]. Identification of S. pneumoniae
likely reflects carriage rather than disease in many pa-
tients, but without testing non-SARI controls to determine
the proportion positive for S. pneumoniae, it is not possible
to definitively decide if S. pneumoniae is being carried or is
causing disease in our study.
We detected viral/viral coinfections in 160/496 (32.3%)
patients tested with assays, and bacteria/viral coinfections
167/199 (83.9%) patients tested with the multiplex (Tables 2,
3, and 4). A study in a similar setting in India reported mul-
tiple infections in 62.4% of hospitalized children [24]. In
Madagascar, dual infections were reported in 27.3% of chil-
dren hospitalized for acute viral infections [21]. Other
studies in resource-limited settings showed comparable
results [26-28].
This work, using sensitive RT-PCR assays, empha-
sizes the need to use different testing methods to identify
pathogens from children with SARI in Lusaka. These
molecular methods demonstrate the need to continuously
monitor and detect new emerging viruses responsibleTable 3 Distribution of co-infections of respiratory
pathogens in SARI patients using singleplex PCR
HRV HPIV 1 HPIV 2 HPIV 3 HPIV 4 RSV HADV HMPV
HRV X 0 1 1 0 10 11 0
HPIV 1 - X 0 0 0 2 0 0
HPIV 2 - - X 0 0 0 4 0
HPIV 3 - - - X 0 1 0 0
HPIV 4 - - - - X 0 0 0
RSV - - - - - X 9 1
HADV - - - - - - X 2
HMPV - - - - - - - Xfor acute respiratory illnesses. Historically, respiratory
illnesses have been associated with influenza virus, re-
spiratory syncytial virus, parainfluenza virus, and adeno-
virus [29,30]. However, with the development of newer,
broad spectrum and sensitive molecular techniques, other
viruses in patients with respiratory tract infections are be-
ing detected [30]. Our results point to the need to further
explore and better understand the role of co-infections in
children. We report a high proportion of dual viral/bacter-
ial infections from the multiplex assay 167/199 (83.9%)
which calls for careful consideration when associating par-
ticular pathogens with specific diseases [31]. Nevertheless,
other data from different studies have repeatedly offered
evidence indicating virus/bacterial coinfections in the re-
spiratory tract [32-35].
In this study, most pathogens were distributed through-
out the year. In Zambia, however, the influenza season is
from May to August, and a larger number of specimens
are collected during this period compared with other times
of year, which may have affected the absolute number of
isolations of pathogens in this study during this time. No
distinct seasonality was observed for most of the respira-
tory pathogens, but RSV and HMPV were preferentially
detected at particular times of the year. A similar pattern
was observed in a study conducted in South Africa, where
particular pathogens (RSV and HPIV-3) were detected at
different times of year while others like HBoV, HRV and
HADV were detected throughout the year [36]. This work
has helped us understand the different pathogens that may
be responsible for respiratory infections in children.
One limitation of our study is that not all eligible chil-
dren meeting case definitions were identified and enrolled,
because even though the University Teaching Hospital is a
reference hospital, patients were free to seek medical at-
tention elsewhere. In addition, we depended on standard
questionnaires to capture all data, and in most cases the
disease outcome was not known because the surveillance
system was not designed to capture all indicators. A re-
lated limitation is lack of case follow-up, meaning that the
disease severities were not recorded. Also, because influ-
enza negative specimens were tested, co-infection rates
among patients infected with influenza virus could not be
examined. Most of the specimens were collected in 2012,
which means that the seasonality we report was primarily
based on 2012. Lastly, this study design did not include
non-SARI controls, and as such we are not able to
Table 4 Distribution of co-infections of respiratory pathogens in SARI patients using multiplex PCR
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HADV - - - - - - X 0 1 0 0 0 0 3 5 0 11 3 0 3 0 5 13 10 1
HPIV 4 - - - - - - - X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EV/PV - - - - - - - X 0 1 0 0 0 0 0 4 0 0 0 0 0 2 0 0
COR
229
- - - - - - - - - X - 0 0 0 0 0 0 0 0 0 0 0 0 0 0
HMPV
AB
- - - - - - - - - - X 0 0 2 2 5 4 1 1 1 0 5 4 1 0
COR
63
- - - - - - - - - - - X 0 0 3 0 3 2 0 1 0 1 3 3 0
COR
HKU
- - - - - - - - - - - - X 0 0 0 0 0 0 0 0 0 0 0 0
HBoV - - - - - - - - - - - - - X 3 0 13 3 1 5 0 5 12 11 0
S.aurs - - - - - - - - - - - - - - X 0 21 1 6 7 0 10 21 18 1
C. pneu. - - - - - - - - - - - - - - - X 2 0 0 0 0 1 1 1 0
S.pneu - - - - - - - - - - - - - - - - X 15 7 19 1 22 64 54 3
HIB - - - - - - - - - - - - - - - - - X 0 7 1 6 15 18 0
PCP - - - - - - - - - - - - - - - - - - X 1 1 7 6 5 2
Legio. - - - - - - - - - - - - - - - - - - - X 0 5 14 17 0
Salm. - - - - - - - - - - - - - - - - - - - - X 2 2 0 1
K.pneu. - - - - - - - - - - - - - - - - - - - - - X 29 21 1
Morax. - - - - - - - - - - - - - - - - - - - - - - X 50 3
Haeinf. - - - - - - - - - - - - - - - - - - - - - - - X 1
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ical diagnosis, and that we cannot determine whether
microbiological findings reflect true infection with causa-
tive agents, or merely colonization in coincidentally ill
children.
Conclusions
This is the first study of viral and bacterial detections in
Zambian children, and we found that viral and bacterial
pathogens were detected from many SARI cases among
hospitalized children in Zambia. The most commonly
identified pathogens were CMV, HADV, RSV, HRV,
HMPV, S. pneumoniae, and M. catarrhalis. These data
cannot determine etiologic significance of the pathogens,
but they provide an indication of the prevalence of each
pathogen in children with SARI. In addition, our study
provides a platform for studies that include non-diseased
controls to better ascertain etiology and more precisely
define the disease burden of various pathogens associ-
ated with SARI among children in Zambia.
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